Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment (2017) Heidkamp GF, Sander J, Lehmann CHK, Heger L, Eissing N, Baranska A, Lühr J, et al. Conference contribution Tumor regression grading after preoperative chemoradiotherapy as prognostic factor and individual-level surrogate for disease-free survival in rectal cancer: Results of the CAO/ARO/AIO-04 multicentre, open-label, randomised, phase 3 trial (2017) Fokas E, Stroebel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer G, Hartmann A, et al. Conference contribution Urothelial Bladder Cancer: An Update on Molecular Pathology with Clinical Implications (2017) Bertz S, Eckstein M, Stoehr R, Weyerer V, Hartmann A Journal article Development and Validation of a Confocal Laser Endomicroscopy-Based Score for In Vivo Assessment of Mucosal Healing in Ulcerative Colitis Patients (2017) Hundorfean G, Chiriac MT, Mihai S, Hartmann A, Mudter J, Neurath M Journal article Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 (2017) Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, El Zimaity H, et al. Journal article Large nested variant of urothelial carcinoma: a clinicopathological study of 36 cases (2017) Comperat E, Mckenney JK, Hartmann A, Hes O, Bertz S, Varinot J, Brimo F Journal article Aquaporin 3 Expression Loss in Urothelial Carcinoma: Association with Tumor Invasion Depth, but not with Grading? (2017) Breyer J, Otto W, Burger M, Hartmann A, Rubenwolf PC Journal article Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity (2017) Van Der Zanden LFM, Vermeulen SH, Oskarsdottir A, Maurits JSF, Diekstra MHM, Ambert V, Cambon-Thomsen A, et al. Journal article Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer (2017) Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, et al. Journal article SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg/CK7pos/HepPar-1pos immunophenotype (2017) Agaimy A, Fuchs F, Moskalev E, Sirbu H, Hartmann A, Haller F Journal article